Han, Z.B.,
Wang, X.X.,
Xu, Z.H.,
Cao, Y.,
Gong, R,
Zagidullin, N.,
Sukhareva, N.,
Zhang, Y. (2021) resection. Conversely, forced expression of ALKBH5 via adeno-associated virus-9 (AAV9) delivery markedly
Karasev, S.M.,
Sufianov, A.A.,
Khafizov, R.R.,
Karaseva, I.I.,
Shugushev, Z.K.,
Maximkin, D.A.,
Khafizov, T.N. (2021) and cosmetic consequences. Existing treatment options include surgical
resection, endovascular embolization
Tao, Pan,
Galiullin, D,
Chen, X.L.,
Zhang, W.H.,
Yang, K,
Liu, K,
Zhao, L.Y.,
Chen, X.Z.,
Hu, J.K. (2021) 2 + lymphadenectomy (OR = 2.64), combined organ
resection (OR = 2.76), and postoperative
Pang, H.Y.,
Chen, X.L.,
Song, X.H.,
Galiullin, D.,
Zhao, L.Y.,
Liu, K,
Zhang, W.H.,
Yang, K,
Chen, X.Z.,
Hu, J.K. (2021) resection. However, more multi-center RCTs with large sample size are required to further verify the value
Pang, H.-Y.,
Zhao, L.-Y,
Zhang, Z.-Q,
Galiullin, D.,
Chen, X.-L.,
Liu, K.,
Zhang, W.-H.,
Yang, K.,
Chen, X.-Z.,
Hu, J.-K. (2021) curative
resection. Methods: A total of 1086 consecutive pT4a patients (101 patients with LG and 985